Testosterona Durateston 250 Pó is a premixed raw-material blend modelled on the four testosterone esters associated with Sustanon 250: Propionato de testosterona, Fenilpropionato de testosterona, Isocaproato de testosterona, and Testosterone Decanoate. AAS Raw Pharma offers the blend with a stated overall assay of 98% or higher for qualified laboratory research, analytical evaluation, formulation development, e fabricação legalmente autorizada.
This product must be described accurately. Durateston 250 is officially a prescription-only finished oil solution, not a single chemical powder. Therefore, “Testosterona Durateston 250 Pó” is a commercial description for a blended raw material containing four distinct testosterone esters. It does not represent one pure active pharmaceutical ingredient with a single molecular formula, peso molecular, or individual-compound CAS number.
The intended blend ratio reflects the ester quantities found in a 1 mL ampoule of the finished Sustanon 250 medicine:
These quantities create a total of 250 mg of testosterone esters, corresponding to approximately 176 mg of testosterone base equivalent in the official finished medicine. The raw blend offered by AAS Raw Pharma is not the branded medicine and should not be described as a ready-to-use 250 mg/mL injectable.
Aviso importante: This listing concerns a bulk chemical blend. Não é um medicamento acabado, solução injetável estéril, suplemento dietético, ou produto de consumo, e não se destina à administração humana ou veterinária direta. Testosterone esters are controlled or prescription-regulated in many jurisdictions. Os compradores são responsáveis por confirmar essa compra, importação, posse, armazenar, processamento, e o uso pretendido são legais.
The name Testosterona Durateston 250 Pó is widely used by raw-material suppliers for a physical mixture of four esterified forms of testosterone. Each ester is a separate chemical substance with its own molecular structure, fórmula, peso molecular, Número CAS, physical characteristics, and analytical profile.
The official Sustanon 250 product is a clear, pale-yellow oil solution containing the four esters in refined arachis oil with benzyl alcohol. Each millilitre contains 30 mg Testosterone Propionate, 60 mg Testosterone Phenylpropionate, 60 mg Testosterone Isocaproate, e 100 mg Testosterone Decanoate. Electronic Medicines Compendium
AAS Raw Pharma’s listing relates instead to the unformulated four-ester blend. It contains no carrier oil or preservative unless expressly stated in the applicable product specification. It has not undergone finished-product formulation, esterilização, concentration adjustment, container-closure validation, or clinical release testing.
| Especificação | Detalhes do produto |
|---|---|
| Nome do produto | Testosterona Durateston 250 Pó |
| Product type | Premixed four-ester testosterone raw-material blend |
| Nomes alternativos | Sustanon raw powder, Sustanon blend, Testosterone four-ester blend |
| Stated overall assay | 98% mínimo, sujeito à documentação do lote |
| Forma física | Powder or crystalline blended solid, subject to batch specification |
| Number of active components | Four separate testosterone esters |
| Target ester ratio | 30:60:60:100 by weight |
| Ratio expressed as parts | 3:6:6:10 |
| Total ratio parts | 25 |
| Propionate target fraction | 12% |
| Phenylpropionate target fraction | 24% |
| Isocaproate target fraction | 24% |
| Decanoate target fraction | 40% |
| Single molecular formula | Not applicable to a physical mixture |
| Single molecular weight | Not applicable to a physical mixture |
| Individual compound CAS number | Not applicable to the complete blend |
| Mixture identifier | CAS 68924-89-0 appears in some databases for the four-component mixture |
| Embalagem | Saco de papel alumínio selado, estanho, or compatible bulk container |
| Documentação | COA específico do lote e informações técnicas, quando disponíveis |
| Usuários pretendidos | Qualified laboratories and legally authorised manufacturers |
| Administração direta | Não permitido; not a finished medicinal product |
The precise blend specification must be confirmed in writing before publication or sale. A raw-material supplier should not call a 25:25:25:25 mixture “Sustanon 250” because equal portions do not match the official 30:60:60:100 ester ratio.
The intended composition can be expressed in several equivalent ways.
| Componente | Official amount per 1 mL finished medicine | Target share of total ester mass | Ratio parts |
|---|---|---|---|
| Propionato de testosterona | 30 mg | 12% | 3 |
| Fenilpropionato de testosterona | 60 mg | 24% | 6 |
| Isocaproato de testosterona | 60 mg | 24% | 6 |
| Decanoato de Testosterona | 100 mg | 40% | 10 |
| Total testosterone esters | 250 mg | 100% | 25 |
The official finished product reports approximately 176 mg of testosterone base per millilitre, even though the combined ester mass is 250 mg. The difference arises because the stated ester masses include both the testosterone portion and each attached ester group. Electronic Medicines Compendium
For a bulk powder blend, the “250” in the product name denotes the reference composition, not an inherent powder concentration. A powder cannot be described in milligrams per millilitre until it has been formulated into a defined solution.
Because this product is a mixture, it should be documented using the identity of every component.
| Componente | Número CAS | Fórmula molecular | Peso molecular |
|---|---|---|---|
| Propionato de testosterona | 57-85-2 | C22H32O3 | 344.49 g/mol |
| Fenilpropionato de testosterona | 1255-49-8 | C28H36O3 | 420.58 g/mol |
| Isocaproato de testosterona | 15262-86-9 | C25H38O3 | Aproximadamente 386.57 g/mol |
| Decanoato de Testosterona | 5721-91-5 | C29H46O3 | Aproximadamente 442.68 g/mol |
NIST and PubChem report CAS 57-85-2, formula C22H32O3, e peso molecular aproximadamente 344.49 for Testosterone Propionate. WebBook de Química do NIST PubChem
The FDA substance record and LGC Standards report CAS 1255-49-8, formula C28H36O3, e peso molecular 420.58 for Testosterone Phenylpropionate. FDA GSRS Padrões LGC
Before publishing the product, AAS Raw Pharma should verify the Isocaproate and Decanoate identifiers against its own component documents and confirm that every batch uses the same four substances.
Não. Testosterona Durateston 250 Powder is not one chemically pure API. It is a physical blend of four APIs or steroidal raw materials.
That distinction affects how the product should be specified and tested:
PubChem carries an entry for a mixture of Testosterone Decanoate, Propionato de testosterona, Fenilpropionato de testosterona, and Testosterone Isocaproate under CAS 68924-89-0. No entanto, database registration of a mixture does not turn it into a single molecular substance, and the entry’s summed formula should not be presented as the formula of one molecule. PubChem
| Characteristic | Testosterona Durateston 250 Pó | Finished Sustanon 250 medicine |
|---|---|---|
| Product type | Premixed raw-material blend | Prescription oil solution |
| Forma física | Powder or crystalline solid blend | Clear, pale-yellow oily liquid |
| Components | Four testosterone ester raw materials | Four testosterone esters plus excipients |
| Carrier | None unless expressly disclosed | Refined arachis oil |
| Preservative | None unless expressly disclosed | Benzyl alcohol |
| Strength | Ratio by mass | 250 mg of esters per mL |
| Testosterone equivalent | Depends on quantity weighed | Aproximadamente 176 mg per mL |
| Sterility | Not implied | Finished-product requirement |
| Ready for injection | Não | Prescription medicine where authorised |
| Regulatory status | Controlled bulk raw material | Regulated medicinal product |
Official product information describes Sustanon 250 as a solution in refined arachis oil, containing benzyl alcohol, and available only by prescription in the jurisdictions reviewed. Electronic Medicines Compendium Medsafe
This distinction should be stated prominently to prevent customers from mistaking the raw blend for a sterile finished ampoule.
For a single substance, an assay may express the percentage of that chemical present. For Testosterona Durateston 250 Pó, an “overall purity of 98%+” is incomplete unless the test report also shows the identities and proportions of the four esters.
A meaningful release specification should consider:
If the four ingredients are each at least 98% pure before blending, that does not automatically prove the final mixture is homogeneous or correctly proportioned. Por outro lado, a single chromatographic purity number cannot confirm that all four intended esters are present in the correct ratio.
AAS Raw Pharma should establish documented acceptance limits around the 12%, 24%, 24%, e 40% target fractions. Those limits should be based on the actual manufacturing and analytical process rather than copied from another supplier.
A technically useful COA might report each ester as a percentage of total ester mass:
| Componente | Target fraction | Batch result |
|---|---|---|
| Propionato de testosterona | 12.0% | Enter actual result |
| Fenilpropionato de testosterona | 24.0% | Enter actual result |
| Isocaproato de testosterona | 24.0% | Enter actual result |
| Decanoato de Testosterona | 40.0% | Enter actual result |
| Total identified ester content | At least 98.0% | Enter actual result |
Do not fill the result column with target values. A target is a manufacturing specification; a result is what the laboratory actually measured.
Individual testosterone esters are generally supplied as crystalline solids. Propionato de testosterona, por exemplo, is described as an odourless white or yellowish-white crystalline material, and established reference suppliers list it as a solid or crystalline solid. PubChem Química Cayman
The final four-component blend may appear white to off-white, but colour alone cannot confirm:
Physical mixing can also produce segregation if the four components differ in particle size, density, electrostatic behaviour, or flow characteristics. Qualified customers should therefore evaluate representative samples rather than relying on appearance or a single top-of-container test.
UM Certificado de Análise, ou COA, for a multi-component blend should contain more information than a COA for one raw compound. Depending on the agreed specification, it may include:
The COA should clearly distinguish between component purity, blend composition, e total assay. Those are related but different quality attributes.
Customers should verify that the lot number on the COA matches the product label. A generic sample COA, another company’s report, or an individual component certificate cannot establish the quality of the final AAS Raw Pharma blend.
Depending on the product specification and intended lawful application, evaluation may include:
AAS Raw Pharma should only claim HPLC, GC-MS, RMN, FTIR, residual-solvent, heavy-metal, particle-size, sterility, or endotoxin testing when the applicable batch documents show that the test was actually performed.
Raw-material supplier pages make inconsistent claims about “Nota USP,” equal 25% component ratios, e 98-99% pureza. One listing describes four components at 25% each, which is not the official Sustanon 250 ratio. Another describes the material as a USP-grade single API even though the product is a blend. These competitor claims should not be copied without technical verification.
No single “Durateston 250 Powder USP” monograph was identified in the authoritative sources reviewed. Official product information covers a finished oil solution, while individual testosterone esters may have their own pharmacopoeial monographs or reference standards.
For example, Testosterone Propionate is available as a USP Reference Standard and as material tested according to the European Pharmacopoeia. Sigma-Aldrich USP Sigma-Aldrich Ph.. EUR. That does not make an arbitrary four-ester powder blend “USP grade.”
AAS Raw Pharma should describe the product as one of the following, depending on documentation:
Avoid “Nota USP,” “GMP certified,” “estéril,” ou “injectable grade” unless those claims are supported by current, product-specific evidence.
Storage instructions for the finished medicine should not be copied automatically onto the raw blend. Official Sustanon 250 ampoules are stored below 30 graus C, protegido da luz, and not refrigerated or frozen because they are oil solutions. Electronic Medicines Compendium
Individual raw esters may have different storage requirements. Reference suppliers list refrigerated or frozen conditions for some neat standards: LGC lists below 4 degrees C for its Testosterone Phenylpropionate reference material, while Cayman Chemical lists -20 degrees C for Testosterone Propionate. Padrões LGC Química Cayman
The correct storage condition for the AAS Raw Pharma blend must therefore come from product-specific stability data, packaging validation, and the applicable COA or SDS.
General professional practice includes:
Do not publish a shelf life or exact temperature unless it is supported by stability data for the complete four-ester blend.
Os ésteres de testosterona são biologicamente ativos e controlados em muitas jurisdições. The blend should be handled only by trained personnel working under an appropriate risk assessment.
Professional controls may include:
Testosterone Propionate is identified as a Schedule III controlled substance by an established reference supplier, and comparable legal controls may apply to other testosterone ester components and the final blend. Química Cayman
The material must not be tasted, engolido, inalado deliberadamente, injetado, ou aplicado diretamente no corpo. Keep it away from children and unauthorised persons. Personnel should review the applicable Safety Data Sheet before opening or processing it.
Sujeito à legislação local, qualificação do cliente, and required licences, this blend may be relevant to:
The product’s availability does not authorise a particular application. Each customer must determine whether its organisation, facility, staff, and intended use satisfy all applicable legal and regulatory requirements.
A raw four-ester blend is fundamentally different from the authorised Testosterone Sustanon 250 oil solution. Producing a regulated sterile medicine requires controls that may include:
An assay of 98% or higher does not demonstrate sterility, liberdade de endotoxinas, concentration accuracy in solution, adequação injetável, segurança clínica, ou aprovação regulatória.
AAS Raw Pharma does not provide conversion, composição, solvente, óleo transportador, filtração, esterilização, injeção, dosagem, ou instruções de administração.
The supplied draft uses Sustanon and Omnadren interchangeably. They are related multi-ester testosterone products, but the names should not be treated as automatically identical.
Product compositions have varied by brand, manufacturer, market, and historical formulation. A page specifically selling a blend modelled on Testosterone Sustanon 250 should define its own four components and ratio instead of relying on Omnadren as a synonym.
For search optimisation, Omnadren may be mentioned once as a related multi-ester testosterone product, but it should not be placed in the product title, principal specification, or schema unless the AAS Raw Pharma blend is genuinely designed and documented to match a named Omnadren formulation.
Packaging should protect the mixed powder from light, umidade, contaminação, segregation, and physical damage. Possible options include:
Every package should identify the product as a four-component blend and include the batch number, quantidade, storage conditions, e informações de manuseio relevantes.
Packaging and customs documentation must describe the goods accurately. AAS Raw Pharma não oferece produtos disfarçados, falsely declared, or deliberately mislabelled shipments.
As amostras podem estar disponíveis para laboratórios qualificados, instituições, e fabricantes autorizados, sujeito a inventário, lei de destino, verificação do cliente, and intended use.
For a quotation, fornecer:
Disponibilidade, quantidade mínima de pedido, capacidade de produção, price, e o prazo de entrega devem ser confirmados em uma cotação formal. Não anuncie “amostras grátis” unless that offer is current, qualified, and governed by clear terms.
AAS Raw Pharma apoia clientes qualificados que buscam matérias-primas esteróides documentadas para aplicações profissionais legais.
The intended blend follows a clearly stated 30:60:60:100 ratio rather than an ambiguous “mixed testosterone” description.
The product carries a stated minimum overall assay of 98%, subject to the results and methods documented for the supplied batch.
Os clientes podem solicitar o COA disponível, especificação, FDS, and supporting technical records before purchase.
O fornecimento direto pode apoiar cotações competitivas para desenvolvimento aprovado e requisitos em massa. Final price depends on quantity, testando, embalagem, availability, e destino.
Qualified customers can discuss ratio tolerances, documentação, embalagem, and testing requirements before the order is accepted.
Packaging can be selected to protect the blend and preserve batch identification throughout lawful storage and transportation.
The sales team can assess logistics options for destinations where exportation, transporte, importação, posse, e o uso pretendido são legais.
Support is available for order records, specifications, batch documentation, embalagem, e consultas de remessa. Any discrepancy should be reported with the relevant order and batch information.
International delivery may be assessed where the transaction and shipment are lawful and accepted by an appropriate carrier. Potential logistics providers may include DHL, FedEx, UPS, TNT, EMS, ou um serviço de frete especializado, depending on destination, quantidade, classificação, and documentation.
The buyer is responsible for confirming:
AAS Raw Pharma does not guarantee customs clearance and does not support false descriptions, values, rótulos, invoices, or declarations.
| Remover ou reescrever | Razão |
|---|---|
| “Durateston 250 injection form” as the product identity | The listed product is raw powder, not finished injection |
| “Ideal compound for putting on size and increasing strength” | Bodybuilding and performance claim |
| “Perfect remedy” for low testosterone | Unqualified medical claim |
| Descriptions of physical, mental, and sexual symptoms | Medical marketing unrelated to raw-material specification |
| Performance-athlete comparisons | Encourages non-medical use |
| “Effective dose: 250-1,000 mg/week” | Orientação sobre dosagem de alto risco |
| “Effective dose for women: not recommended” | Personal-use dosing context |
| Cycle reviews, active-life, and detection-time fields | Doping and self-administration content |
| Injection-frequency recommendations | Administration guidance |
| “500-1,000 mg por semana” discussion | Unsafe performance-enhancement instructions |
| “Quality guarantee 100%” | Alegação absoluta não fundamentada por um relatório de lote |
| “100% taxa personalizada” | Pouco claro e inverificável |
| “Embalagem bem disfarçada” | Sugere evasão alfandegária ou de detecção |
| Guaranteed fast delivery to named countries | May be false where import controls apply |
This page provides technical and commercial information about a controlled raw-material blend. It does not recommend Testosterone Sustanon 250 Powder for testosterone replacement, musculação, muscle gain, strength enhancement, desempenho atlético, ou qualquer aplicativo pessoal.
Sem dosagem, injeção, ciclo, empilhamento, tratamento, or detection-time guidance is included. Those details are inappropriate for a bulk raw material and could facilitate unsafe or unlawful use.
Any legitimate treatment of testosterone deficiency requires clinical diagnosis, medical supervision, and a lawfully authorised finished medicine. The official Testosterone Sustanon 250 product is prescription-only in the jurisdictions reviewed. Medsafe Healthdirect
Testosterona Durateston 250 Pó is a commercial name for a blended raw material containing Testosterone Propionate, Fenilpropionato de testosterona, Isocaproato de testosterona, and Testosterone Decanoate.
Não. It is a mixture of four separate testosterone esters and therefore does not have one molecular formula or one molecular weight.
The intended ratio is 30:60:60:100, equivalent to 12%, 24%, 24%, e 40% by total ester mass.
The official finished medicine contains a total of 250 mg of the four testosterone esters per millilitre. For raw powder, “250” refers to that model composition and is not itself a concentration.
Não. Official product information states that 250 mg of the four esters corresponds to approximately 176 mg of testosterone base. Electronic Medicines Compendium
AAS Raw Pharma lists a stated overall assay of 98% or higher, subject to batch-specific documentation. The COA should also report the identity and proportion of each ester.
PubChem associates CAS 68924-89-0 with a mixture containing the four esters. The individual component CAS numbers should still appear in the technical documentation.
Não. The branded product is a prescription oil solution containing the four esters, refined arachis oil, and benzyl alcohol. The AAS Raw Pharma listing concerns an unformulated raw blend.
Not unless the product specification expressly says so. A dry blend should contain the four raw ester components and no carrier oil or preservative.
A esterilidade não deve ser assumida. Unless an exact batch has been manufactured, testado, e liberado de acordo com uma especificação estéril documentada, it must be treated as non-sterile raw material.
Não. It is not a finished, estéril, ajustado por concentração, or authorised injectable medicine.
A documentação do lote pode estar disponível mediante solicitação. Buyers should confirm that the COA reports each component’s identity, proportion, and the overall assay.
Follow the exact conditions on the AAS Raw Pharma label, COA, and SDS. Conditions for the finished oil solution should not automatically be applied to the raw powder.
As amostras podem estar disponíveis para clientes qualificados, sujeito a inventário, verificação, uso pretendido, lei de destino, e condições comerciais.
Bulk enquiries may be reviewed according to quantity, component availability, testing requirements, qualificação do cliente, and destination regulations.
A entrega internacional pode ser possível quando a exportação, transporte, importação, posse, e o uso pretendido são legais.
Não. The purchaser is responsible for permits, declarações, obrigações, impostos, e requisitos do país de destino.
Não. Dosagem, injeção, ciclo, empilhamento, and performance-use instructions are inappropriate for a bulk raw material.
Forneça a quantidade, destino, detalhes da organização, uso legal pretendido, required ratio, ensaio, embalagem, documentação, and applicable permits.
